Dermatomyositis Epidemiology Forecast Report 2034 Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The "Dermatomyositis - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. The "Dermatomyositis - Epidemiology...

Idiopathic Inflammatory Myositis Industry Assessment, 2020-2034: Breakthrough Therapies (Dazukibart and Efgartigimod) Propel Market Expansion Across the 7MM Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "Idiopathic Inflammatory Myositis - Market Insights, Epidemiology, and Forecast to 2034" report has been added to ResearchAndMarkets.com's offering. ...

Dermatomyositis Epidemiology Forecast to 2032: In-Depth Analysis of Prevalent Cases and Growth Opportunities in the 7MM Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Dermatomyositis - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Researchers have now compiled a...

Dermatomyositis Market Insights, Epidemiological Forecast to 2032: Advances, Emerging Therapies, and Growth Opportunities Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Dermatomyositis - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This...

Potential applications & Growth of Dermatomyositis Drug Market in Pharmaceutical Industry NEW YORK, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Dermatomyositis (DM) is an idiopathic (disease for which cause is unknown) inflammatory disorder of skin and skeletal muscle involvement. Patients with...